BIO

BIO

BIO

BiaMix is a company dedicated to providing custom reagent mixes designed for biotech experiments.
Founded
2007
Follow us
Alexa global traffic share
Twitter followers
Team Size
50+
Employees
Location
Headquarters
Xconomy

Vir Advances Antibodies Against COVID-19, CEO Leads BIO’s Coronavirus Outreach

Technical.ly Delaware

Delaware BIO launched a virtual coronavirus hub

Xconomy

BIO Report: More Work Needed to Improve Diversity at Biotech Firms

Xconomy

Biotech VC Down 20% in US as Policies Drive Away Foreign Investors, BIO

MedCity News

Party at BIO conference that featured topless dancers draws fire from organization

MedCity News

Gates Foundation debuts nonprofit biotech firm at BIO

Robotics
Xconomy

Bio Roundup: Wrapping ASCO, Dreaming IPO, Rebooting Axovant & More

Health Science
MedCity News

Janssen sees a potential myeloma CAR-T edge, exec says at BIO

MedCity News

Experts at BIO, ASCO weigh in on CAR-Ts versus bispecific antibodies

Xconomy

At Opioid Hearing, BIO Exec Proposes Ways to Boost Pain Drug Development

Health Privacy
Xconomy

As Trump Budget Addresses Opioid Crisis, BIO Report Reveals Scarce Pain Drug Development

Health
Xconomy

Bio Roundup: RNAi Drama, Immunotherapy Data, Lasker Winners & More

Health Funding
Xconomy

Bio Roundup: Termeer Tribute, ASCO Peeks, Califf’s New Gigs & More

Health
Xconomy

Bio Roundup: CRISPR Drama, Marathon and PhRMA, the Price of Vision & More

Robotics Health Science
Xconomy

Bio Roundup: Fast "Cures," Trump In Time, CRISPR In Court & More

Health Science